Healthcare

Health Care Originals Wins Top Honors at SuperCrowdLA Pitch Competition with AI Respiratory Monitoring Technology

Health Care Originals Wins Top Honors at SuperCrowdLA Pitch Competition with AI Respiratory Monitoring Technology

Health Care Originals, led by CEO Sharon Samjitsingh, swept the SuperCrowdLA Live Pitch Competition by winning both Judges' and Audience Choice Awards for its innovative AI-powered respiratory monitoring technology, signaling potential breakthrough in chronic respiratory condition management.

May 11, 2025
Highland Park Dentist Offers Revolutionary Self-Administered Pain Relief Technique for Migraines and Headaches

Highland Park Dentist Offers Revolutionary Self-Administered Pain Relief Technique for Migraines and Headaches

Dr. Ira Shapira teaches patients and medical professionals a self-administered technique for Sphenopalatine Ganglion (SPG) Blocks, offering rapid pain relief for migraines, cluster headaches, and other autonomic cephalgias using a minimally invasive method.

May 10, 2025
Documentary Highlights Resilience of Disabled Motorcycle Racers at Le Mans

Documentary Highlights Resilience of Disabled Motorcycle Racers at Le Mans

A new documentary 'Le Mans, Racing Beyond Limits' offers an intimate look at the European Motorcycle Championship for Riders with Disabilities, showcasing athletes who transcend physical limitations through competitive racing.

May 10, 2025
Calidi Biotherapeutics Unveils Promising Cancer Treatment Platform with Broad Therapeutic Potential

Calidi Biotherapeutics Unveils Promising Cancer Treatment Platform with Broad Therapeutic Potential

Calidi Biotherapeutics has demonstrated preclinical success with its RTNova platform, showing the ability to deliver gene-therapy payloads and kill over 60 tumor cell lines, potentially transforming cancer treatment approaches.

May 9, 2025
Diplomatic Trade Acquires Major Stake in Turkish Pharmaceutical Company, Targets $300M IPO

Diplomatic Trade Acquires Major Stake in Turkish Pharmaceutical Company, Targets $300M IPO

Diplomatic Trade Ltd and its investment arm have secured a 49% equity position in a Turkish pharmaceutical company, with plans to launch a bio-manufacturing facility in the UAE and pursue a potential $300 million IPO in late 2025.

May 9, 2025
Research Uncovers Early Development Patterns of Pediatric Brain Tumors

Research Uncovers Early Development Patterns of Pediatric Brain Tumors

A new study explores the complex origins of medulloblastoma in specialized nerve cells, potentially offering insights for future treatment strategies in pediatric brain cancer.

May 9, 2025
Nutriband Advances Abuse-Deterrent Fentanyl Patch in Response to Opioid Crisis

Nutriband Advances Abuse-Deterrent Fentanyl Patch in Response to Opioid Crisis

Nutriband is developing an innovative abuse-deterrent transdermal fentanyl patch amid shifting FDA regulations and ongoing efforts to combat opioid misuse. The technology represents a potential breakthrough in safer pain management strategies.

May 9, 2025
ABVC BioPharma Secures Japanese Patent for Innovative Depression Treatment

ABVC BioPharma Secures Japanese Patent for Innovative Depression Treatment

ABVC BioPharma has obtained a Japanese patent for its botanical-based Major Depressive Disorder treatment ABV-1504, expanding its global intellectual property portfolio and positioning the company for potential market entry in Japan's robust pharmaceutical landscape.

May 9, 2025
Zil Money Achieves HIPAA Certification, Elevating Data Security for Business Payments

Zil Money Achieves HIPAA Certification, Elevating Data Security for Business Payments

Zil Money Corporation has obtained HIPAA certification, demonstrating its commitment to protecting sensitive financial and healthcare-related data through advanced security protocols and compliance standards across its payment technology platform.

May 9, 2025
Vascular Surgeon Dr. Michael Lebow Launches National Scholarship for Aspiring Medical Professionals

Vascular Surgeon Dr. Michael Lebow Launches National Scholarship for Aspiring Medical Professionals

A $1,000 scholarship aimed at supporting undergraduate students committed to healthcare careers offers financial assistance and recognition for future medical professionals. The award highlights the importance of nurturing emerging talent in the medical field.

May 9, 2025
Local Hospital Leader Steve Sanchez Receives Rural Health Excellence Award

Local Hospital Leader Steve Sanchez Receives Rural Health Excellence Award

Steve Sanchez, Community Relations Manager at Southeast Colorado Hospital, was honored by the Colorado Rural Health Center for his exceptional contributions to rural healthcare advocacy and community service. The award recognizes his significant efforts in improving healthcare access and support in rural Colorado.

May 9, 2025
Adageis Launches AI-Powered Platform to Revolutionize Healthcare Billing and Insurance Payments

Adageis Launches AI-Powered Platform to Revolutionize Healthcare Billing and Insurance Payments

Adageis introduces an innovative AI-driven software platform that helps healthcare providers optimize revenue, improve financial transparency, and navigate complex insurance reimbursement processes with greater efficiency.

May 8, 2025
Simple Eye Exam Could Enable Early Parkinson's Detection, Researchers Find

Simple Eye Exam Could Enable Early Parkinson's Detection, Researchers Find

A new study from Universite Laval suggests that a straightforward retinal examination might provide an early diagnostic method for Parkinson's disease, potentially transforming how medical professionals identify and track the neurological condition.

May 8, 2025
Hydromer Reports Q1 Revenue Decline Amid Strategic Reinvestment

Hydromer Reports Q1 Revenue Decline Amid Strategic Reinvestment

Medical coatings company Hydromer experienced a revenue and earnings decrease in Q1 2025, yet remains committed to strategic investments and long-term growth in the medical device technology sector.

May 8, 2025
Clene Inc. Advances CNM-Au8 Toward Potential Accelerated Approval for ALS

Clene Inc. Advances CNM-Au8 Toward Potential Accelerated Approval for ALS

Clene Inc. reports promising progress on its CNM-Au8 therapy for ALS, with plans to submit a New Drug Application under the FDA's Accelerated Approval pathway, supported by significant survival data and reduced expenses.

May 8, 2025
Clene Inc. Advances Promising Therapy for ALS, Targets Accelerated FDA Approval

Clene Inc. Advances Promising Therapy for ALS, Targets Accelerated FDA Approval

Clene Inc. reports significant progress on CNM-Au8, a potential breakthrough therapy for amyotrophic lateral sclerosis (ALS), with plans to submit a New Drug Application under the FDA's Accelerated Approval pathway in Q4 2025. New data demonstrates improved patient survival and neurological repair.

May 8, 2025
TransCode Therapeutics Advances RNA Cancer Therapy, Reaches Milestone in Phase 1a Trial

TransCode Therapeutics Advances RNA Cancer Therapy, Reaches Milestone in Phase 1a Trial

TransCode Therapeutics has successfully dosed 15 patients in its Phase 1a trial for RNA-based cancer therapeutic TTX-MC138, with early data showing promising target engagement and no significant toxicities.

May 8, 2025
NanoViricides Secures Ethics Approval for Mpox Phase II Trial in Democratic Republic of Congo

NanoViricides Secures Ethics Approval for Mpox Phase II Trial in Democratic Republic of Congo

NanoViricides has received ethical clearance to conduct a Phase II clinical trial for NV-387, a broad-spectrum antiviral drug targeting Mpox, signaling potential progress in viral disease treatment strategies.

May 8, 2025
Nancy Brown Named to TIME's 2025 List of Most Influential Health Leaders

Nancy Brown Named to TIME's 2025 List of Most Influential Health Leaders

Nancy Brown, CEO of the American Heart Association, has been recognized by TIME magazine as one of the 100 most influential individuals in global health, highlighting her transformative leadership in cardiovascular research and health innovation.

May 8, 2025
Scinai Immunotherapeutics Turns Financial Corner with $4.8 Million Net Gain

Scinai Immunotherapeutics Turns Financial Corner with $4.8 Million Net Gain

Biotechnology company Scinai Immunotherapeutics reports a significant financial turnaround in 2024, transforming a previous year's loss into a net gain through strategic financial management and early revenue generation.

May 8, 2025
GeoVax Reveals Promising Dual-Action Vaccine with Potential COVID-19 and Mpox Protection

GeoVax Reveals Promising Dual-Action Vaccine with Potential COVID-19 and Mpox Protection

A novel vaccine candidate, GEO-CM04S1, demonstrates robust immunogenicity against both COVID-19 and Mpox in immunocompromised and healthy populations, offering potential breakthrough in infectious disease prevention.

May 8, 2025
SSDI Benefits Group Launches AI Tool to Streamline Disability Application Process

SSDI Benefits Group Launches AI Tool to Streamline Disability Application Process

SSDI Benefits Group introduces an AI-powered platform designed to guide disability benefit applicants with personalized, real-time support, addressing common challenges in the application process and reducing uncertainty.

May 8, 2025
Holistic Healing Practitioner Expands Expertise with Advanced Brain and Lymphatic Therapy Training

Holistic Healing Practitioner Expands Expertise with Advanced Brain and Lymphatic Therapy Training

Carol McCoon, a holistic healing practitioner, is advancing her professional skills through specialized training in Brain Therapy and Lymph Drainage Therapy, offering personalized healing techniques that address neurological and lymphatic dysfunctions.

May 7, 2025
Telomir Pharmaceuticals Advances Neurological Research with Novel Cellular Restoration Candidate

Telomir Pharmaceuticals Advances Neurological Research with Novel Cellular Restoration Candidate

Telomir Pharmaceuticals reveals promising preclinical data for Telomir-1, a small molecule targeting cellular decline, with potential applications in autism spectrum disorder and rare neurological conditions. The research demonstrates potential breakthrough in understanding age-related cellular deterioration.

May 7, 2025
Clene Inc. to Present at D. Boral Capital Global Conference in New York

Clene Inc. to Present at D. Boral Capital Global Conference in New York

Clene Inc., a late clinical-stage biopharmaceutical company developing neurological disease treatments, will participate in the D. Boral Capital Inaugural Global Conference, offering investors an opportunity to learn about its innovative research and potential therapeutics.

May 7, 2025
Dynamic Global Events to Host Life Science Meeting Planners Summit in Philadelphia

Dynamic Global Events to Host Life Science Meeting Planners Summit in Philadelphia

Dynamic Global Events will convene top life science industry professionals for a networking and information-sharing summit in Philadelphia, addressing critical collaboration needs in the sector.

May 7, 2025
Soligenix CEO Highlights Rare Disease Therapeutics and Public Health Solutions Strategy

Soligenix CEO Highlights Rare Disease Therapeutics and Public Health Solutions Strategy

Soligenix's CEO discusses the company's two-pronged business model focused on rare disease treatments and public health solutions, emphasizing significant government funding and promising clinical trial developments.

May 7, 2025
GeoVax Secures New Patent for Innovative Cancer Treatment Approach

GeoVax Secures New Patent for Innovative Cancer Treatment Approach

GeoVax Labs has received a Notice of Allowance for a patent describing a novel triple-combination cancer therapy strategy targeting solid tumors with potential to minimize systemic toxicity and enhance treatment effectiveness.

May 7, 2025
Femto Technologies Secures Patent for Smart Release System Technology in Femtech Innovation

Femto Technologies Secures Patent for Smart Release System Technology in Femtech Innovation

Femto Technologies has received a Notice of Allowance from the U.S. Patent and Trademark Office for its proprietary Smart Release System technology, reinforcing its position as an AI-driven feminine wellness innovator and highlighting the potential for advanced technology in personal health solutions.

May 7, 2025
Plastic Surgery Private Equity Firm Expands with Acquisition of Arkansas Cosmetic Practice

Plastic Surgery Private Equity Firm Expands with Acquisition of Arkansas Cosmetic Practice

Olympus Cosmetic Group has acquired the practice of Dr. Suzanne Yee, a triple board-certified surgeon in Little Rock, Arkansas, marking a strategic expansion of its network of top-tier cosmetic surgery practices. The acquisition highlights a growing trend of private equity investment in specialized medical practices.

May 7, 2025
PreviousPage 72 of 80Next